key: cord-0724012-xwyp6tyg
authors: Harrill, Willard C.
title: Vaping during the COVID‐19 pandemic: NOT GOOD!!
date: 2020-04-20
journal: Laryngoscope Investig Otolaryngol
DOI: 10.1002/lio2.386
sha: 06c94f011d42c2cf2c7dd7ecd2ae2d1f7aa8ee8e
doc_id: 724012
cord_uid: xwyp6tyg

nan

forget last year's very relevant epidemic of e-cigarette, or vaping, product use-associated lung injury (EVALI). EVALI risk within the vaping public represents a substantial escalation of preventable co-morbid risk that can dramatically and negatively impact the pulmonary inflammatory morbidity and mortality of COVID-19 if social behaviors are not effectively and dramatically curbed through effective public health measures. Within this epidemic/pandemic cycle, it is especially alarming that the footprint of the EVALI epidemic nearly mirrors that of current COVID-19 pandemic reported cases, thus matching regional social behavior risk with current regional pandemic risk 1,2 ( Figure 1 

Update: interim guidance for health care providers evaluating and caring for patients with suspected Ecigarette, or vaping, product use associated lung injury -United States

reports-studies/national-cancer-opinion-survey?cmpid-vanity-survey=

Quick-Facts-on-the-Risks-of-E-cigarettes-for-Kids-Teens-and-Young-Adults.html. Accessed

JUUL electronic cigarette use patterns, other tobacco product use, and reasons for use among ever users: results from a convenience sample